Quva Pharma Inc News Today

/PRNewswire/ -- Ernst & Young LLP (EY US) today announced that CEO and co-founder, Stuart Hinchen, and CDO and co-founder Peter Jenkins of QuVa Pharma were...

Seemingly everyone is beginning to pay more attention to Washington’s efforts to regulate AI.

/PRNewswire/ -- The compounding pharmacy market size is estimated to grow by USD 1,682.04 million from 2022 to 2027. The market is estimated to accelerate at a...

/PRNewswire/ -- QuVa Pharma, Inc. announced today that it received the 2023 Supplier Legacy Award from Premier, Inc., a leading healthcare improvement and...

Companys RFID products will now adhere to GS1 standards to support open and interoperable medication management solutions, traceability, and improved efficiency and safety for hospitals and health systems

/PRNewswire/ -- The compounding pharmacy market size is set to grow by USD 1.5 billion from 2021 to 2026. In addition, the growth momentum of the market will...

SUGAR LAND, Texas, Jan. 18, 2022 /PRNewswire/ -- QuVa Pharma, Inc., a leading national 503B outsourcing services company to U.S. hospitals, and its parent company, QuVa Pharma Holdings, Inc. ...

/PRNewswire/ -- QuVa Pharma, Inc., a leading national 503B outsourcing services company to U.S. hospitals, and its parent company, QuVa Pharma Holdings, Inc....

/PRNewswire/ -- QuVa Pharma, Inc., a leading national 503B outsourcing services company to U.S. hospitals, and its parent company, QuVa Pharma Holdings, Inc....

QuVa Pharma Completes $275 Million Financing with Syndicate Led by Goldman Sachs Following Multiple Years of Strong Growth, Financing Further Validates 503B Industry Value Proposition, Demonstrates Strength of QuVa Pharma and Attractiveness of Ongoing Business Growth Initiatives News provided by Share this article Share this article SUGAR LAND, Texas, May 6, 2021 /PRNewswire/ -- QuVa Pharma, Inc.("QuVa Pharma"), the leading national 503B outsourcing services company providing hospitals with es...